DK3515416T3 - Plaster der omfatter kaliumpermanganat til behandling af hudlidelse - Google Patents

Plaster der omfatter kaliumpermanganat til behandling af hudlidelse Download PDF

Info

Publication number
DK3515416T3
DK3515416T3 DK17777332.2T DK17777332T DK3515416T3 DK 3515416 T3 DK3515416 T3 DK 3515416T3 DK 17777332 T DK17777332 T DK 17777332T DK 3515416 T3 DK3515416 T3 DK 3515416T3
Authority
DK
Denmark
Prior art keywords
treatment
potassium permanganate
skin disorders
containing potassium
plasters containing
Prior art date
Application number
DK17777332.2T
Other languages
English (en)
Inventor
Charles Heard
David Houston
Keith Harding
Original Assignee
Onya Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Onya Therapeutics Ltd filed Critical Onya Therapeutics Ltd
Application granted granted Critical
Publication of DK3515416T3 publication Critical patent/DK3515416T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/32Manganese; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
DK17777332.2T 2016-09-23 2017-09-21 Plaster der omfatter kaliumpermanganat til behandling af hudlidelse DK3515416T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1616223.2A GB201616223D0 (en) 2016-09-23 2016-09-23 Topical treatment patch
PCT/GB2017/052816 WO2018055376A1 (en) 2016-09-23 2017-09-21 Patch comprising potassium permanganate for the treatment of skin disorder

Publications (1)

Publication Number Publication Date
DK3515416T3 true DK3515416T3 (da) 2023-09-04

Family

ID=57539902

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17777332.2T DK3515416T3 (da) 2016-09-23 2017-09-21 Plaster der omfatter kaliumpermanganat til behandling af hudlidelse

Country Status (19)

Country Link
US (1) US11129800B2 (da)
EP (1) EP3515416B1 (da)
JP (1) JP7066692B2 (da)
KR (1) KR102552765B1 (da)
CN (1) CN109982688B (da)
AU (1) AU2017332832B2 (da)
BR (1) BR112019005722A8 (da)
CA (1) CA3037807A1 (da)
DK (1) DK3515416T3 (da)
ES (1) ES2954142T3 (da)
GB (1) GB201616223D0 (da)
HU (1) HUE063088T2 (da)
IL (1) IL265581B2 (da)
MX (1) MX2019003347A (da)
PL (1) PL3515416T3 (da)
PT (1) PT3515416T (da)
RU (1) RU2770064C2 (da)
WO (1) WO2018055376A1 (da)
ZA (1) ZA201902228B (da)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791632A (fr) * 1971-11-20 1973-05-21 Schering Ag Supports a base de caoutchouc siliconique pour agents medicamenteux
US3839246A (en) * 1973-08-09 1974-10-01 Gen Electric Two-part room temperature vulcanizable systems
GB1412970A (en) * 1974-01-15 1975-11-05 Schering Ag Pharmaceutical preparations containing silicone rubber
JPS59104314A (ja) * 1982-11-09 1984-06-16 Hisamitsu Pharmaceut Co Inc 新規貼付薬
JP2659961B2 (ja) * 1986-08-18 1997-09-30 中外製薬株式会社 経皮吸収貼付剤
US5792090A (en) * 1995-06-15 1998-08-11 Ladin; Daniel Oxygen generating wound dressing
JPH10158155A (ja) * 1996-11-29 1998-06-16 Tac Medical Kk 貼付剤
DE60233217D1 (de) * 2001-05-01 2009-09-17 Corium Internat Inc Hydrogel-zusammensetzungen
US20030180281A1 (en) * 2002-03-11 2003-09-25 Bott Richard R. Preparations for topical skin use and treatment
JP2004321785A (ja) * 2003-04-07 2004-11-18 Ube Ind Ltd 医療用パッチ及びその製造方法
CA2554649C (en) * 2004-01-30 2015-10-27 Corium International, Inc. Rapidly dissolving film for delivery of an active agent
CA2596529C (en) * 2005-01-27 2014-08-19 Corium International, Inc. Hydrophilic biocompatible adhesive formulations and uses
JP2006248996A (ja) * 2005-03-10 2006-09-21 Nitto Denko Corp 経皮吸収型貼付剤
DE102006025282A1 (de) * 2006-05-31 2007-12-20 Lts Lohmann Therapie-Systeme Ag Selbstzerstörendes transdermales therapeutisches System
DE102008016804B4 (de) * 2008-04-02 2012-01-05 Lts Lohmann Therapie-Systeme Ag Selbstzerstörendes transdermales therapeutisches System mit verbesserter Funktionalität und Wirksamkeit sowie seine Verwendung
CN104271160B (zh) * 2012-04-27 2017-08-08 道康宁公司 包含基于有机硅的赋形剂以将活性物质递送到基底的局部用制剂组合物
CN103819799B (zh) * 2014-03-07 2016-02-24 福州大学 一种聚合物/高锰酸钾复合薄膜及其制备方法
EP3258978A4 (en) 2015-02-16 2018-10-31 CTM@CRC Ltd. Methods and products for delivering cells
EP3446693B1 (en) * 2015-02-19 2020-11-11 Hiantis S.r.l. Pharmaceutical compositions and formulations comprising aluminium acetate for topical application with astringent and antimicrobial effect
ES2691407T3 (es) * 2015-04-28 2018-11-27 Frank Dicosmo Vendajes adhesivos antimicrobianos

Also Published As

Publication number Publication date
EP3515416B1 (en) 2023-06-07
PT3515416T (pt) 2023-09-07
CN109982688B (zh) 2023-08-15
CN109982688A (zh) 2019-07-05
WO2018055376A1 (en) 2018-03-29
CA3037807A1 (en) 2018-03-29
KR102552765B1 (ko) 2023-07-10
AU2017332832A1 (en) 2019-04-18
JP7066692B2 (ja) 2022-05-13
MX2019003347A (es) 2019-10-07
IL265581A (en) 2019-05-30
JP2019533648A (ja) 2019-11-21
RU2019112100A (ru) 2020-10-23
IL265581B2 (en) 2023-04-01
AU2017332832B2 (en) 2023-04-27
KR20190080869A (ko) 2019-07-08
US20190224133A1 (en) 2019-07-25
ZA201902228B (en) 2022-12-21
EP3515416A1 (en) 2019-07-31
IL265581B (en) 2022-12-01
RU2019112100A3 (da) 2020-12-11
GB201616223D0 (en) 2016-11-09
RU2770064C2 (ru) 2022-04-14
PL3515416T3 (pl) 2024-01-15
BR112019005722A2 (pt) 2019-07-09
HUE063088T2 (hu) 2023-12-28
BR112019005722A8 (pt) 2023-04-11
ES2954142T3 (es) 2023-11-20
US11129800B2 (en) 2021-09-28

Similar Documents

Publication Publication Date Title
DK3570844T3 (da) Azolopyrimidin til behandlingen af kræftrelaterede lidelser
DK3728271T3 (da) Makrocykliske forbindelser til behandling af sygdomme
DK3347030T3 (da) Brug af pasteuriseret akkermansia til behandling af stofskiftesygdomme
DK3119397T3 (da) Heterocykliske forbindelser til anvendelse i behandling af PI3K-gamma-medierede lidelser
DK3362066T3 (da) Kombinationsterapi til behandling af maligniteter
DK3481846T3 (da) 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande
DK3240612T3 (da) Fremgangsmåder til behandling af nethindesygdomme
DK3390390T3 (da) Bipyrazolylderivater egnede til behandling af autoimmunsygdomme
DK3498278T3 (da) Forbindelser til behandling af sygdomme relateret til DUX4-ekspression
DK3240538T3 (da) Anvendelse af masitinib til behandling af en underpopulation af patienter med amyotrofisk lateralsklerose
DK3331879T3 (da) Benzazolforbindelser og fremgangsmåder til fremstilling og anvendelse af forbindelserne
DK3524255T3 (da) Sammensætning til behandling af acne
DK3157534T3 (da) Acetylcholinesterasehæmmere til behandling af dermatologiske tilstande
DK3258919T3 (da) Næsepulverformulering til behandling af hypoglykæmi
DK3430143T3 (da) Inhibitorer af SRSF1 til behandlingen af neurodegenerative sygdomme
DK3324867T3 (da) Indretning til akut behandling af hjertestop
DK3191103T3 (da) Sammensætninger og fremgangsmåder til behandling af præcancerøse hudlæsioner
DK3271015T3 (da) Nk-3-receptorantagonister til terapeutisk eller kosmetisk behandling af overskydende kropsfedt
DK2994157T3 (da) Tafa4-forbindelser og anvendelser deraf til behandling af smerte
DK3416580T3 (da) Enhed til bestråling af huden
DK3097085T3 (da) Benzoxazinonderivater til behandling af hudsygdomme
DK3256466T3 (da) 1-heterocyclyl-isochromanylforbindelser og analoger til behandling af cns-forstyrrelser
DK3612208T3 (da) Coversin til behandlingen af autoimmune sygdomme med blisterdannelse
DK3506901T3 (da) Anvendelse af kynurensyre til behandling af muskelatrofi
DK3286317T3 (da) Dynamin 2-inhibitor til behandlingen af duchennes muskeldystrofi